Disparities in Time to Treatment for Breast Cancer: Existing Knowledge and Future Directions in the COVID-19 Era

• Published in: Current breast cancer reports Vol. 14; no. 4; pp. 213 - 221
• Main Authors: Fasano, Genevieve A., Bayard, Solange, Gillot, Tamika, Hannibal, Zuri, Pedreira, Marian, Newman, Lisa
• Format: Journal Article
• Language: English
• Published: New York Springer US 01.12.2022
• Subjects: Breast Cancer Disparities (LA Newman; Breast Cancer Disparities (LA Newman, Section Editor); Internal Medicine; Medicine; Medicine & Public Health; Oncology; Section Editor; Surgical Oncology; Topical Collection on Breast Cancer Disparities; Time to treatment; Disparities; Breast cancer; Cancer screening
• ISSN: 1943-4588; 1943-4596
• DOI: 10.1007/s12609-022-00469-9

Purpose of Review Despite significant advances in detection and treatment for breast cancer, the breast cancer mortality rate for Black women remains 40% higher than that for White women. Timely work-up and treatment improve outcomes, yet no gold standard exists for which to guide providers. Recent Findings A large body of literature demonstrates disparities in time to treatment for breast cancer, and most studies show that Black women receive treatment later than their White counterparts. The COVID-19 pandemic has been projected to worsen these disparities, but the extent of this impact remains unknown. Summary In this review, we describe the available evidence on disparities in time to treatment, potential drivers, and possible mitigation strategies. Future research must address how the COVID-19 pandemic has impacted the timely treatment of breast cancer patients, particularly populations vulnerable to disparate outcomes. Improved access to multidisciplinary breast programs, patient navigation services, and establishment of standards for timely treatment are necessary.